PFD report

Fallon Leanne ADAMS · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 29 Dec 2025•Cambridgeshire and Peterborough

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
2

Raised in this report

Recipients
1

Named on the report

Responses found
1

Of 1 recipient

Stated actions
3

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised2

  1. Potential for over-sedation and death from combined sedative medications
    Part of recurring concern: Inadequate controls for combined sedative medication toxicityPart of recurring concern: Toxicity risks from excessive or combined medication use
  2. Failure to provide and implement specific warnings about the risks of over-sedation from additional non-prescribed medication
    Part of recurring concern: Failure to communicate clinically significant medication risks to patientsPart of recurring concern: Inadequate controls for combined sedative medication toxicity
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.3

  1. Action

    Remind prescribing clinicians to assess and manage cumulative sedative burden, recognise oversedation, repeat unexpected observations, document findings and escalation decisions, and escalate concerns proactively.

    Stated by Northamptonshire Healthcare NHS Foundation TrustStated completedThe respondent said that this action was complete when they made their response on 5 January 2026.
  2. Action

    Introduce and routinely provide patients with a harm-minimisation leaflet covering polypharmacy, illicit substances, substance use alone, reduced tolerance, and medication initiation or titration risks.

    Stated by Northamptonshire Healthcare NHS Foundation TrustStated completedThe respondent said that this action was complete when they made their response on 5 January 2026.
  3. Action

    Remind secure-environment prescribers to discuss medication purposes, risks, interactions, follow-up, and document contemporaneous consultation advice.

    Stated by Northamptonshire Healthcare NHS Foundation TrustStated completedThe respondent said that this action was complete when they made their response on 5 January 2026.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Potential for over-sedation and death from combined sedative medications

Wider context from the report

“• Whilst an inmate at HMP Peterborough Fallon ADAMS was prescribed methadone (for opiate withdrawal) and chlordiazepoxide (for alcohol withdrawal). She also took non-prescribed ████████ apparently obtained from an illicit source within the prison. All of these medications have a sedative effect which in combination have the potential to cause over sedation and death. • The evidence seemed to show that at no stage was Ms ADAMS given a specific warning or advice stating that taking additional non-prescribed medication ████████ could result in over sedation and death. • I also heard evidence in relation to Regulation 28 issues. Whilst it is clear that a number of relevant changes were being made it was not clear that a specific warning in relation to the risks of over sedation was being implemented. ”

Is this part of a recurring concern?

Yes — Inadequate controls for combined sedative medication toxicity; Toxicity risks from excessive or combined medication use.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to provide and implement specific warnings about the risks of over-sedation from additional non-prescribed medication

Wider context from the report

“• Whilst an inmate at HMP Peterborough Fallon ADAMS was prescribed methadone (for opiate withdrawal) and chlordiazepoxide (for alcohol withdrawal). She also took non-prescribed ████████ apparently obtained from an illicit source within the prison. All of these medications have a sedative effect which in combination have the potential to cause over sedation and death. • The evidence seemed to show that at no stage was Ms ADAMS given a specific warning or advice stating that taking additional non-prescribed medication ████████ could result in over sedation and death. • I also heard evidence in relation to Regulation 28 issues. Whilst it is clear that a number of relevant changes were being made it was not clear that a specific warning in relation to the risks of over sedation was being implemented. ”

Is this part of a recurring concern?

Yes — Failure to communicate clinically significant medication risks to patients; Inadequate controls for combined sedative medication toxicity.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Remind prescribing clinicians to assess and manage cumulative sedative burden, recognise oversedation, repeat unexpected observations, document findings and escalation decisions, and escalate concerns proactively.

Verbatim wording from the response

“In response to your Report, we have reminded our prescribing clinicians of our expectations concerning the assessment and management of cumulative sedative burden, recognition of over-sedation, and the need for proactive escalation where concerns are identified.”

Source location

Response from Northamptonshire Healthcare Foundation Trust
Page 3 · response
Published 5 January 2026

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Introduce and routinely provide patients with a harm-minimisation leaflet covering polypharmacy, illicit substances, substance use alone, reduced tolerance, and medication initiation or titration risks.

Verbatim wording from the response

“We have also introduced a new harm minimisation advice leaflet, which is now routinely provided to patients. This leaflet clearly outlines key risks, including polypharmacy, the use of illicit drugs alongside prescribed medication, the dangers of using substances alone in cells (particularly overnight), reduced tolerance following periods of abstinence, and the increased risk associated with medication initiation and titration periods.”

Source location

Response from Northamptonshire Healthcare Foundation Trust
Page 3 · response
Published 5 January 2026

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Remind secure-environment prescribers to discuss medication purposes, risks, interactions, follow-up, and document contemporaneous consultation advice.

Verbatim wording from the response

“We agree it is important that a patient is informed about the risk(s) of any medication(s) our clinicians prescribe, including those that may arise from interactions with other medications they may be taking, whatever the source.”

Source location

Response from Northamptonshire Healthcare Foundation Trust
Page 2 · response
Published 5 January 2026

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
1/1

Data last updated 7 September 2026